Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384:766–81.
Hu ST, Gao RL, Liu LS, Zhu ML, Wang W, Wang YJ, et al. Summary of the 2018 report on cardiovascular diseases in China. Chin Circulation J. 2019;34:209–19.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.
Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75:285–92.
Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012;122:3035–43.
Razvi S, Jabbar A, Pingitore A, Danzi S, Biondi B, Klein I, et al. Thyroid hormones and cardiovascular function and diseases. J Am Coll Cardiol. 2018;71(16):1781–96.
Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14:39–55.
Du Y, Zhu B, Liu Y, Zhou W, Du Z, Yang W, et al. Association between nocturnal blood pressure phenotype and adverse cardiovascular prognosis in patients with coronary heart disease and hypertension. J Clin Hypertens (Greenwich). 2024;26:405–15.
Vidal-Petiot E, Stebbins A, Chiswell K, Ardissino D, Aylward PE, Cannon CP, et al. Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial. Eur Heart J. 2017;38:2813–22.
Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13:3–126.
Koulouri O, Moran C, Halsall D, Chatterjee K, Gurnell M. Pitfalls in the measurement and interpretation of thyroid function tests. Best Pract Res Clin Endocrinol Metab. 2013;27:745–62.
Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab. 2007;92:491–6.
Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep. 2003;5:513–20.
Nie X, Xu Y, Ma X, Xiao Y, Wang Y, Bao Y. Association between abdominal fat distribution and free triiodothyronine in a euthyroid population. Obes Facts. 2020;13:358–66.
Taneichi H, Sasai T, Ohara M, Honma H, Nagasawa K, Takahashi T, et al. Higher serum free triiodothyronine levels within the normal range are associated with metabolic syndrome components in type 2 diabetic subjects with euthyroidism. Tohoku J Exp Med. 2011;224:173–8.
Chen H, Xi Q, Zhang H, Song B, Liu X, Mao X, et al. Investigation of thyroid function and blood pressure in school-aged subjects without overt thyroid disease. Endocrine. 2012;41:122–9.
Xu R, Huang F, Zhang S, Lv Y, Liu Q. Thyroid function, body mass index, and metabolic risk markers in euthyroid adults: a cohort study. BMC Endocr Disord. 2019;19:58.
Le TN, Celi FS, Wickham EP. 3rd. Thyrotropin levels are associated with cardiometabolic risk factors in euthyroid adolescents. Thyroid. 2016;26:1441–9.
Tarcin O, Abanonu GB, Yazici D, Tarcin O. Association of metabolic syndrome parameters with TT3 and FT3/FT4 ratio in obese Turkish population. Metab Syndr Relat Disord. 2012;10:137–42.
Abdi H, Gharibzadeh S, Tasdighi E, Amouzegar A, Mehran L, Tohidi M, et al. Associations between thyroid and blood pressure in euthyroid adults: a 9-year longitudinal study. Horm Metab Res. 2018;50:236–41.
Kim BJ, Kim TY, Koh JM, Kim HK, Park JY, Lee KU, et al. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Clin Endocrinol (Oxf). 2009;70:152–60.
Delitala AP, Scuteri A, Fiorillo E, Lakatta EG, Schlessinger D, Cucca F. Role of adipokines in the association between thyroid hormone and components of the metabolic syndrome. J Clin Med. 2019. https://doi.org/10.3390/jcm8060764.
Mehran L, Amouzegar A, Tohidi M, Moayedi M, Azizi F. Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects. Thyroid. 2014;24:1566–74.
Amouzegar A, Heidari M, Gharibzadeh S, Mehran L, Tohidi M, Azizi F. The association between blood pressure and normal range thyroid function tests in a population based Tehran thyroid study. Horm Metab Res. 2016;48:151–6.
Park SB, Choi HC, Joo NS. The relation of thyroid function to components of the metabolic syndrome in Korean men and women. J Korean Med Sci. 2011;26:540–5.
Shin KA, Kim EJ. Association between thyroid hormone and components of metabolic syndrome in euthyroid Korean adults: a population-based study. Medicine (Baltimore). 2021;100:e28409.
Giontella A, Lotta LA, Overton JD, Baras A, On Behalf Of Regeneron, Genetics C, Sartorio A, et al. Association of thyroid function with blood pressure and cardiovascular disease: a Mendelian randomization. J Pers Med. 2021. https://doi.org/10.3390/jpm11121306.
Lin SY, Wang YY, Liu PH, Lai WA, Sheu WH. Lower serum free thyroxine levels are associated with metabolic syndrome in a Chinese population. Metabolism. 2005;54:1524–8.
Mosley JD, Gupta DK, Tan J, Yao J, Wells QS, Shaffer CM, et al. Predictive accuracy of a polygenic risk score compared with a clinical risk score for incident coronary heart disease. JAMA. 2020;323:627–35.
Gu Y, Zheng L, Zhang Q, Liu L, Meng G, Yao Z, et al. Relationship between thyroid function and elevated blood pressure in euthyroid adults. J Clin Hypertens (Greenwich). 2018;20:1541–9.
Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression–based approach. New York. 2013;1st:85–122.
Ittermann T, Tiller D, Meisinger C, Agger C, Nauck M, Rettig R, et al. High serum thyrotropin levels are associated with current but not with incident hypertension. Thyroid. 2013;23:955–63.
Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Recent advances in thyroid hormone regulation: toward a new paradigm for optimal diagnosis and treatment. Front Endocrinol (Lausanne). 2017;8:364.
Wahab A, Dey AK, Bandyopadhyay D, Katikineni V, Chopra R, Vedantam KS, et al. Obesity, systemic hypertension, and pulmonary hypertension: a tale of three diseases. Curr Probl Cardiol. 2021;46:100599.
Higgins M, Kannel W, Garrison R, Pinsky J, Stokes J. 3rd. Hazards of obesity–the Framingham experience. Acta Med Scand Suppl. 1988;723:23–36.
Flamant F, Samarut J. Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab. 2003;14:85–90.
Zhang J, Lazar MA. The mechanism of action of thyroid hormones. Annu Rev Physiol. 2000;62:439–66.
Roef GL, Rietzschel ER, Van Daele CM, Taes YE, De Buyzere ML, Gillebert TC, et al. Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects. Thyroid. 2014;24:223–31.
Kitahara CM, Platz EA, Ladenson PW, Mondul AM, Menke A, Berrington de González A. Body fatness and markers of thyroid function among U.S. men and women. PLoS One. 2012;7:e34979.
Boggio A, Muzio F, Fiscella M, Sommariva D, Branchi A. Is thyroid-stimulating hormone within the normal reference range a risk factor for atherosclerosis in women? Intern Emerg Med. 2014;9:51–7.
Lee YK, Kim JE, Oh HJ, Park KS, Kim SK, Park SW, et al. Serum TSH level in healthy Koreans and the association of TSH with serum lipid concentration and metabolic syndrome. Korean J Intern Med. 2011;26:432–9.
Park HT, Cho GJ, Ahn KH, Shin JH, Hong SC, Kim T, et al. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas. 2009;62:301–5.
Kim HJ, Bae JC. Triiodothyronine levels are independently associated with metabolic syndrome in euthyroid middle-aged subjects. Endocrinol Metab. 2016;31:311–9.
Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010;316:165–71.
Sriram N, Hunter GR, Fisher G, Brock DW. Resting energy expenditure and systolic blood pressure relationships in women across 4.5 years. J Clin Hypertens (Greenwich). 2014;16:172–6.
Ittermann T, Thamm M, Wallaschofski H, Rettig R, Völzke H. Serum thyroid-stimulating hormone levels are associated with blood pressure in children and adolescents. J Clin Endocrinol Metab. 2012;97:828–34.
Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501–9.
Izzo R, Cipolletta E, Ciccarelli M, Campanile A, Santulli G, Palumbo G, et al. Enhanced GRK2 expression and desensitization of BetaAR vasodilatation in hypertensive patients. Clin Transl Sci. 2008;1:215–20.
Ciccarelli M, Sorriento D, Coscioni E, Iaccarino G, Santulli G. Endocrinology of the heart in health and disease. Cambridge, MA: Academic; 2017. pp. 285–315. (Chap. 11: Adrenergic Receptors).
Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension. J Clin Hypertens (Greenwich). 2006;8:596–9.
Gumieniak O, Perlstein TS, Hopkins PN, Brown NJ, Murphey LJ, Jeunemaitre X, et al. Thyroid function and blood pressure homeostasis in euthyroid subjects. J Clin Endocrinol Metab. 2004;89:3455–61.
Senese R, Lasala P, Leanza C, de Lange P. New avenues for regulation of lipid metabolism by thyroid hormones and analogs. Front Physiol. 2014;5:475.
Mancini A, Di Segni C, Raimondo S, Olivieri G, Silvestrini A, Meucci E, et al. Thyroid hormones, oxidative stress, and inflammation. Mediators Inflamm. 2016;2016:6757154.
Fernández-Real JM, López-Bermejo A, Castro A, Casamitjana R, Ricart W. Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab. 2006;91:3337–43.
Michalaki MA, Vagenakis AG, Leonardou AS, Argentou MN, Habeos IG, Makri MG, et al. Thyroid function in humans with morbid obesity. Thyroid. 2006;16:73–8.
Li J, Peng Y, Ji K. Brachial pulse pressure is associated with the presence and extent of coronary artery disease in stable angina patients: a cross-sectional study. BMC Cardiovasc Disord. 2020;20:143.
Tsai TY, Leu HB. Association between visit-to-visit blood pressure variability and adverse events in coronary artery disease patients after coronary intervention. J Clin Hypertens (Greenwich). 2022;24:1327–38.
Abbaoui Y, Fortier C, Desbiens LC, Kowalski C, Lamarche F, Nadeau-Fredette AC, et al. Accuracy difference of noninvasive blood pressure measurements by sex and height. JAMA Netw Open. 2022;5:e2215513.
Nolde JM, Beaney T. Age-related blood pressure gradients are associated with blood pressure control and global population outcomes. Hypertension. 2024;81:2091–100.
Picone DS, Schultz MG, Otahal P, Black JA, Bos WJ, Chen CH, et al. Influence of age on upper arm cuff blood pressure measurement. Hypertension. 2020;75:844–50.
Wyse CA, Celis Morales CA, Ward J, Lyall D, Smith DJ, Mackay D, et al. Population-level seasonality in cardiovascular mortality, blood pressure, BMI and inflammatory cells in UK biobank. Ann Med. 2018;50:410–9.
Narita K, Hoshide S, Kario K. Seasonal variation in blood pressure: current evidence and recommendations for hypertension management. Hypertens Res. 2021;44:1363–72.
Saltiki K, Voidonikola P, Stamatelopoulos K, Mantzou E, Papamichael C, Alevizaki M. Association of thyroid function with arterial pressure in normotensive and hypertensive euthyroid individuals: a cross-sectional study. Thyroid Res. 2008;1:3.
Luboshitzky R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid. 2002;12:421–5.